OTC · AHKSY
Basic Materials · Chemicals
$20.70
Up+$0.50 (+2.48%)
Updated Sep 16, 2026, 6:35 PM
SID Score
6.7/10
Composite research score
Smart Money
46/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
AHKSY does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning AHKSY.
AHKSY research
Company profile and research snapshot.
ASAHI KAISEI CRP UNSP/ADR
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Sep 8, 2026
TOKYO, September 08, 2026--Asahi Kasei Microdevices has announced that its CZ39 and CZ3K series have been adopted as in Microchip Technology's ML/AI-based AFD reference design.
Yahoo · Aug 31, 2026
Veloxis Pharmaceuticals, Inc. (Veloxis), a global specialty pharmaceutical company part of Asahi Kasei Corporation, today announced that the first participant has been dosed in its Phase 2 clinical trial [NCT07290777] of pegrizeprument, a novel investigational maintenance immunosuppressive agent being studied for prevention of organ rejection in kidney transplant recipients.
Yahoo · Aug 26, 2026
TOKYO, August 26, 2026--Asahi Kasei held a grand opening ceremony for its new Hipore™ wet-process lithium-ion battery separator coating line in Charlotte, North Carolina.
SeekingAlpha · Aug 7, 2026
2026-08-07. The following slide deck was published by Asahi Kasei Corporation in conjunction with their 2027 Q1 earnings call.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AHKSY.
No results
No recent SID articles mention AHKSY.
